Home › Research › Risk factors
Age-Related Speech-in-Noise Hearing Loss in Parkinson’s Disease and APOE E4 Carriers
Kmiecik MJ, Xu W, Weldon CH, Guan A, McIntyre MH, Bouchard EL, 23andMe Research Team, Schneider RB et al.. medRxiv, 2026-06-09
Topic: Genetics and APOE
Plain-language summary
Age-related hearing loss is a leading modifiable risk factor for dementia and is increasingly recognized as a non-motor feature of Parkinson’s disease (PD). The apolipoprotein E ( APOE ) E4 allele is the strongest genetic risk factor for Alzheimer’s disease and is associated with cognitive decline in PD, yet its relationship to hearing loss remains unclear. Therefore, we examined the independent and interactive effects of PD status and APOE E4 carrier status on age-related hearing loss using a validated web-based speech-in-noise (SIN) assessment in 239,620 23andMe Research Institute participants without PD and 4,361 PD cases. Generalized additive models for location, scale, and shape (GAMLSS) showed that both PD and APOE E4 independently exacerbated age-related hearing decline, with speech reception thresholds (SRTs) worsening non-linearly with advancing age, but without evidence of synergistic interaction. However, longitudinal analyses in a subcohort completing at least two assessments (1,434 PD cases; 36,242 controls) using GAMLSS mixed models showed a significant three-way interaction between PD status, APOE E4, and age 2 , such that SIN hearing loss accelerated more steeply with age in APOE E4 carriers with PD. Males and individuals with lower educational attainment also exhibited worse SIN hearing loss. These results identify APOE E4 carriers with PD as a priority population for hearing screening and intervention, and support the integration of SIN assessments into routine PD care to detect hearing decline that may compound cognitive and communicative burden in aging.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Kmiecik, M. J., Xu, W., Weldon, C. H., Guan, A., McIntyre, M. H., Bouchard, E. L., et al. (2026). Age-Related Speech-in-Noise Hearing Loss in Parkinson’s Disease and APOE E4 Carriers. medRxiv. https://doi.org/10.64898/2026.06.08.26355175
Vancouver
Kmiecik MJ, Xu W, Weldon CH, Guan A, McIntyre MH, Bouchard EL, et al. Age-Related Speech-in-Noise Hearing Loss in Parkinson’s Disease and APOE E4 Carriers. medRxiv. 2026. doi:10.64898/2026.06.08.26355175.
BibTeX
@article{kmiecik2026-a3ec8995,
author = {Kmiecik, M. J. and Xu, W. and Weldon, C. H. and Guan, A. and McIntyre, M. H. and Bouchard, E. L. and {23andMe Research Team} and Schneider, R. B. and others},
title = {{Age-Related Speech-in-Noise Hearing Loss in Parkinson’s Disease and APOE E4 Carriers}},
journal = {medRxiv},
year = {2026},
doi = {10.64898/2026.06.08.26355175},
url = {https://doi.org/10.64898/2026.06.08.26355175}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- The apolipoprotein E ( APOE ) E4 allele is the strongest genetic risk factor for Alzheimer’s disease and is associated with cognitive decline in PD, yet its relationship to hearing loss remains unclear.
- Generalized additive models for location, scale, and shape (GAMLSS) showed that both PD and APOE E4 independently exacerbated age-related hearing decline, with speech reception thresholds (SRTs) worsening non-linearly with advancing age, but without evidence of synergistic interaction.
- However, longitudinal analyses in a subcohort completing at least two assessments (1,434 PD cases; 36,242 controls) using GAMLSS mixed models showed a significant three-way interaction between PD status, APOE E4, and age 2 , such that SIN hearing loss accelerated more steeply with age in APOE E4 carriers with PD.
- These results identify APOE E4 carriers with PD as a priority population for hearing screening and intervention, and support the integration of SIN assessments into routine PD care to detect hearing decline that may compound cognitive and communicative burden in aging.
New to this subject? Start with our plain-English guide: Risk factors, ranked →
Study details
- Study designlongitudinal study
- Evidence strengthModerate
How this study scored 16/100
Preprint — not yet peer-reviewed. It scored 35 on the same rubric, but non-peer-reviewed sources are capped at 16, so it shows as 16. Scored zero for sample size, effect reported, studied in people and randomized / blinded because the record does not state it. We have no data on times cited, citations per year, impact for its field and year, cited by studies here, still being cited, senior author's track record, institution's track record and multicenter collaboration, so those were left out: it earned 22 of the 62 points we could judge it on, which is 35 out of 100.
| Component | Points | Why |
|---|---|---|
| Journal tier | 2 / 10 | Tier 4 — not a peer-reviewed journal (medRxiv) |
| Journal's citation record | 0 / 4 | Not a journal article, so the journal's record does not count |
| Study design | 7 / 12 | A longitudinal study following the same people over time |
| Strength of evidence | 3 / 5 | Rated “moderate” in our summary |
| Peer-review validation | 4 / 10 | Preprint — not yet peer-reviewed. Hosted on a preprint server. |
| How recent | 5 / 5 | 2026 — within 1 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | — / 7 | No citation count (not found in OpenAlex) — left out of this score |
| Citations per year | — / 5 | No citation count or no year — left out of this score |
| Impact for its field and year | — / 6 | No field-weighted citation impact (OpenAlex has none yet) — left out of this score |
| Cited by studies here | — / 6 | Not yet checked against this library's citation graph — left out of this score |
| Still being cited | — / 4 | No yearly citation counts — left out of this score |
| Senior author's track record | — / 4 | Senior author's record not available — left out of this score |
| Institution's track record | — / 3 | No institution listed in OpenAlex — left out of this score |
| Multicenter collaboration | — / 3 | Institutions not listed — left out of this score |
| Indexed in PubMed | 1 / 2 | Not in PubMed, but has a DOI |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Points | 22 / 62 | Scored on 12 of 20 parts. We have no data for the rest, so they are left out: 22 of the 62 points we could judge it on is 35 out of 100. |
| Total | 35 / 100 | Capped to 16 because this is not a peer-reviewed article. |
What each of these 20 components measures, and what this score is not →
Read the original
Free copy unknown: no free-copy check has an answer for this record yet. That does not mean it is paywalled.
Related
Studies in the library that share something with this one. The line above each title says what.
Related studies in Risk factors from nearby years
Also tagged “hearing”
119 studies in the library carry the topic tag “hearing”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 119 tagged studies.